# 0197 — Adversarial review of milestones 1 to 3 against their claims

Status: COMPLETE. PM disposed all verified review findings in463c3e2a:0201 containment,0202 desktop tools,0203 cleanup policy,0204 bundle recovery, bounded0151 coverage read, and stale documentation fixes. Read-only review evidence archived and independently verified onYellow; no review scratch remains.

Milestone: 3

## Outcome

A fresh read-only reviewer runs the adversarial project review over landed main for milestones 1 to 3 (gene, article, variant, trial, drug, disease and the foundations) and reports each finding with evidence, severity and the claim it contradicts. The PM turns each confirmed finding into a ticket or a recorded ruling.

- Why: milestones 1 to 3 are nearly complete, and the shared adversarial-project-review skill requires a review at each milestone's end.
- Starts from: the shared adversarial-project-review skill; ROADMAP.md's ticked boxes; architecture.md, slices.md and the landed slice designs; the outside-in suite, coverage floor and ratchets; the nightly live check report; 0060's process lines.
- Rules: read-only. No product change, no provider call and no key use. The reviewer checks code, tests, security, stored state, concurrency, docs, tickets, packaging and release against what the roadmap and designs claim, and checks each ticked box against landed evidence. Clinical questions go to a clinical reviewer. Findings that only restate an open ticket are listed as such, not refiled.
- Proof: the report goes to the evidence store with the reviewed revision. The PM records each finding's disposition on this ticket.
